Technology Transfer / Patents & Licensing
USF Start-up Companies
At the Office of Technology Transfer, one of our primary goals is to foster the growth of new businesses based on University of South Florida research. We work with inventors, entrepreneurs, and investors to create successful transitions from innovation to new enterprise.
Below is a list of USF start-up businesses that have grown from USF technology.
AbleNook is a rapidly deployable portable structure comprised of interlocking components which can be assembled by unskilled laborers in a short period of time (without tools). These components are shipped flat-packed in order to maximize the number of families who are helped in disaster areas, while reducing transportation costs.
Agilis Biotherapeutics is advancing innovative DNA therapeutics designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central nervous system.
Aqua Access LLC provides innovative technology development,
product commercialization, and consulting to serve the water needs of mankind.
Cahaba Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of clinical stage drug therapies targeting both the molecular basis of cancer and side effects of cancer treatment.
Cellular Biomedicine Group, Inc. is a biomedicine company, principally engaged in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. We are focused on developing and marketing safe and effective cell-based therapies based on our cellular platforms that represent a large unmet need in China, such as cancer, orthopedic diseases (including osteoarthritis and tissue damage), various inflammatory diseases and metabolic diseases.
St. Petersburg, FL
Claro Scientific, LLC is focused on commercializing a platform diagnostic system that analyzes samples and delivers better information, faster and at lower cost than other systems on the market or under development.
Boca Raton, FL
ClearSpec LLC, a division of MDI Worldwide, is the developer of a new, patented and FDA cleared device, which is scientifically proven by an IRB randomized clinical study to improve visualization of the cervix for every exam. ClearSpec addresses many of the problems associated with proper visualization, diagnosis and treatment of cervical disease, improving patient outcomes for women worldwide.
CuPRx is a drug discovery company focused on the trace-metal causes of disease. We focus on new compounds and new compositions of matter for the creation of therapeutics that will target metal metabolism and metal disruptions. Our goal is to do this in a unique way that mitigates and potentially eliminates toxic side-effects of pharmaceuticals.
CvergenX, Inc. is an early stage advanced diagnostic services company that was founded to provide personalized medicine tools for the field of radiation oncology. The Company's Intervene XRT testing platform applies genomic analysis to predict a tumor's response to radiation and to assist the oncologist in determining the optimal level of radiation dosing. CvergenX joins a growing group of personalized medicine companies that are applying genomics-basis analysis to clinical practice to enable a more personalized and accurate approach to patient care.
Winter Garden, FL
Formerics, LLC is a digital modeling company focusing on the creation of analysis suitable geometric models from irregular physical objects such as advanced engineered glassy polymer composites, biological tissues, and other materials.
West Palm Beach, FL
Gordian Biotechnologies is developing first-in-class, novel, reversible b-lactamase inhibitors that when combined with existing antibiotics are effective against a broad spectrum of drug-resistant Gram-negative pathogens. By combining an FDA approved antibiotic with the company's novel -lactamase inhibitors, Gordian disarms the bacteria's resistance mechanism, allowing the antibiotic to defeat the pathogen.
GLG Pharma, LLC, a Florida biotechnology company, is developing a series of patented inhibitors of Signal Transducer and Activators of Transcription 3 (STAT3). Four inhibitors have been selected for development and are in advanced preclinical stage.
St. Petersburg, FL
HPV Therapeutics, Inc. is a wholly owned subsidiary of IRX Therapeutics, Inc. HPV-TI holds a sub-license from IRX Therapeutics and the University of South Florida for global, exclusive rights to develop and commercialize the IRX-2 immunomodulatory technology for the treatment of human papillomavirus ("HPV") induced diseases of the reproductive organs.
St. Petersburg, FL
Imigene makes bacterial infections transparent.
Innovatia Medical Systems designs and develops high performance medical devices for Minimally Invasive Surgery. Innovatia was formed to support and commercialize the work of USF's Miniature Anchored Remote Videoscope for Expedited Laparoscopy (MARVEL) research team of engineering students headed by Dr. Richard Gitlin.
Insight Innovations LLC introduces a new video and audio program for ART trained clinicians and their clients. The computer based program duplicates the hand movement used during ART therapy, eliminates the need for counting, and can prevent physical strain on the therapist.
St. Petersburg, FL
Intelligent Micro Patterning is where researchers go when they need unique, novel, and imaginative thin film solutions. Using our patented smart filter technology that is the heart of our maskless lithography product offerings, our company partners with technologists that seek new, unique and innovative technologies to accomplish their goals.
Moving to St. Petersburg
IRX Therapeutics is focused on making cancer treatments better. IRX develops immune therapies designed to activate a patient's immune system to defeat cancer and related diseases.
KeriCure Inc is a medical device company that specializes in research and development of topical products with a focus on wound care.
Kineta Two is a subsidiary of Kineta Inc., a nationally-recognized biotechnology company focused on developing leading edge therapeutics in three large high need therapeutic areas: autoimmune disease, viral disease and chronic pain. Kineta Two offers a superb clinical stage antiviral candidate to meet unprecedented global demand for new drugs for infectious diseases. rOAS1 is a novel recombinant antiviral protein with broad activity against multiple viruses such as influenza, Dengue, hepatitis C and RSV
Life Enabling Technologies provides innovative, patented accessories for disabled individuals confined to wheelchairs. The unique on-board, disappearing tray table gives the user more independence and enhances their quality of life. Combined with LET's automatic back pack Storage and Retrieval system, disabled individuals have greater freedom to enjoy life on their own terms.
Looshes Labs Skate, LLC has designed and created a skateboard and longboard with built in storage. Items such as tablet computers, smart phones, wallet, keys, and any other personal accessories fit easily and safely inside. Each board is handmade and must pass through several stages of quality control. Looshes Labs is the only company that has been licensed this technology for manufacturing and distribution.
Metabogenix Technologies, Inc., is a biotechnology company focused on the discovery and development of drugs targeting
the microenvironment of solid tumors as novel treatments for patients living with
cancer. Metabogenix has devised technologies using analogs of sugar in combination
with other chemoagents to target these slow-growing tumor cell populations. Based
on groundbreaking work in which it was shown that one of these analogs could indeed
kill slow growing cells of solid tumors in animal models and when combined with a
standard chemotherapeutic drug which targets the fast growing cells leads to increased
treatment efficacy, a Phase I clinical trial was completed.
MMI began its business in 1998 as a supplier of single crystal sapphire fibers. Since then, it has expanded its product lines to include fiber-optic temperature sensors as well as chemical sensors.
MiMedx Group is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products. The company is committed to the commercialization of Biomaterials that improve surgical outcomes by solving an unmet or underserved clinical need.
Modelithics is the premier provider of high-precision measurements and models for microwave/RF design simulation. They have the experience, equipment, and knowledge to accurately measure components and build software models that enable popular circuit simulation tools to generate more accurate predictions of as-built performance. Simply put, you will move from concept to product faster with Modelilthics models
Modulation Therapeutics is an early stage biotech company dedicated to the cost-effective advancement of first in class molecules to improve patient outcomes in unmet medical needs such as relapsed multiple myeloma and AML two hematopoietic tumors characterized by homing to the bone marrow and solid tumors that metastasize to the bone including lung, breast and prostate.
Moterum, Inc. - The gait enhancing mobile shoe (GEMS) alters the wearer's gait by causing one foot to move backward during the stance phase while walking over ground. No external power is required since the shoe mechanically converts the wearer's downward and horizontal forces into a backward motion. This shoe allows a patient to walk over ground while experiencing the same gait altering effects as felt on a split-belt treadmill, which should aid in transferring the corrected gait to walking in natural environments.
My Reviewers is a suite of web-based tools and resources that help teachers and students save time while providing more effective feedback on student writing. Developed at the University of South Florida, instructors have used My Reviewers to assess over 100,000 essays. In addition, students have used My Reviewers to conduct over 20,000 peer reviews.
Natura Therapeutics, Inc. is a science-based company committed to providing high quality nutritional products researched and developed by its team of leading experts in the fields of nutritional science and stem cell research.
The company focuses on medical devices, namely, transcranial electromagnetic treatment devices. The primary goal of NeuroEM Therapeutics is to clinically test and market TEMT as an effective prevention and treatment against Alzheimer's disease.
Novel Bio-Spectrum Technologies, Inc. works in the areas of Cloning, Western Blots, Cell Culture, Transfections, RNA Isolation, In Vitro Transcription and PCR.
Ovation Diagnostics LLC is dedicated to developing advanced and accessible ovarian cancer diagnostic technologies to address a global unmet need.
Phoinix Holding, LLC commercializes patented breakthrough healthcare/life science technologies developed by USF research scientists that make life easier and better for all living things.
Prescient Therapeutics (PTX) is a clinical stage oncology company developing novel compounds that show great promise as potential new therapies to treat a range of solid and hematological cancers. The Company's novel compounds inhibit key tumor survival pathways, inhibiting cancer growth and overcoming resistance to prior therapies.
Primack & Associates, LLC is currently developing the Dynamic Alphabet (DynA) Phonics Reading Software System. DynA utilizes a patented technology to animate and articulate phonic sounds, making it challenging, entertaining, engaging, and fun for children learning to read.
Treasure Island, FL
PureMolecular LLC provides services and technology for microbiological testing and seafood quality control. The company has developed an amplification assay that enables identification of the majority of fish labeled as groupers from less valuable substitutes. PureMolecular, LLC offers seafood authentication services as well as field instrumentation and reagent kits for "point of use" seafood verification.
Saneron is a biotechnology R&D company, focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which lack adequate treatment options.
The Scientific League was formed to make learning an interactive, engaging, and enriching experience. Through use of modern multimedia-based technologies we develop robust content focused on education in Science, Technology, Engineering, and Mathematics (STEM).
St. Petersburg, FL
Spyglass Technologies, Inc. is a business-to-business water technology company that enables its customers to analyze the biological and chemical composition of their water resources and provides water sensors and software to a range of markets including oil and gas exploration and production, industrial water treatment and purification, coastal water quality monitoring and oceanographic and fresh water research.
STEM Genesis bridges the gap between early-stage research and commercial product development. We use proven business models that leverage government funding to advance early-stage technology to establish proof of concept, build prototypes, and validate performance. We then use private sources of capital to advance technology development, increase value, reduce risk and attract commercialization partners.
TransGenex Nanobiotech, Inc. is a Florida-based biotechnology company dedicated to discovering and developing nanoparticle formulations and nano-encapsulation methods for use against novel targets to treat acute and chronic lung diseases and cancers. Current products include Chitosan Nanoparticles, Magnetic Nanoparticles, Hybrid Particles (polymer-magnetic), Functionalized Nanoparticles, and an HIV diagnostic kit.
Trash 2 Cash-Energy has over twenty years of experience in the catalysis industry and is focused on taking landfill gas to liquid fuel. Catalytic production of renewable feedstock to energy is at the heart of our company's interest.
VioQuest Pharmaceuticals, Inc. acquires, develops, and commercializes targeted late preclinical and early clinical stage therapies with unique mechanisms of action for oncology, viral and autoimmune disorders. A pioneer in personalized therapeutics, VioQuest has two targeted therapeutics in clinical trials: VQD-001, an inhibitor of specific protein tyrosine phosphatases, has shown compelling preclinical activity in both renal and melanoma cancers and VQD-002 which has shown to inhibit the phosphorylation of Akt which can be seen in abnormal levels in breast, ovarian, colorectal, pancreatic, and hematologic malignancies.
Toronto, Ontario, Canada
Viteava's mission is to leverage the growing body of positive human clinical data with green tea extracts, to develop novel chemical entities with enhanced potency and bioavailability, ideally suited to early intervention in the treatment and management of cancer and related conditions.
St. Petersburg, FL
WT1 Short Peptide Therapeutics, Inc., a Delaware corporation headquartered in St. Petersburg, Florida, will initially be a 100% owned subsidiary of IRX Therapeutics, Inc. WT1S-TI will hold a sub-license from IRX Therapeutics and the University of South Florida for global, exclusive rights to develop and commercialize the IRX-2 immunomodulatory technology for use with Wilm's tumor gene-based short peptide cancer vaccines for the treatment of prostate cancer.